Montreal, Canada · Founded 2021 · Privately Held (backing)
Operator of a computationally-driven biotechnology company intended to discover novel drugs. Congruence Therapeutics is based in Montreal, Canada and was founded in 2021. It has raised $137 million.
Last price · $/share
—
Implied valuation
—
Total raised
$136.5M
Last round
—
Cap table — not yet on record
Congruence Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Congruence Therapeutics with a free account
·The complete investor list: 14 names
·Watch Congruence Therapeutics: the Monday email on marks, rounds and moves
